The local Commercial Head of a tier II global pharma company could not retain talent, and team turnover was >50% YoY. Operations were resented, as well as business results.
Switzerland: Go/ no-go decision launch of Rx product and OTC extension.
The local management of a tier-1 global pharma company wanted to understand the interest and sustainability of launching a Rx retail product in Switzerland, potentially an OTC line extension of the same product, and the impact on their own local product portfolio.
A tier 1 branded pharma products wanted to align skills & capabilities of MM / BM new hires, and optimize the yearly creation and update of marketing plans.
Zarzia understood perfectly our needs and has helped us to find new products to expand our portfolio. BD Director, Europe
Find us on:
EU e-Privacy Directive
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.